Adenine Deoxy Nucleoside

Also known as: Adenosine Adenyldeoxyriboside Deoxyadenosine Desoxyadenosine Adenine Deoxyribonucleoside Adenine Deoxyribose Adenine Nucleoside Adenine Riboside

Active ingredient description

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Adenosine
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Medicines

Adenine Deoxy Nucleoside is the active ingredient of these drugs:

Drug
Countries

Brazil Canada United States

Estonia Ireland Lithuania Netherlands New Zealand

France Hong Kong Spain United Kingdom

Turkey

Japan

Romania Turkey

Estonia Lithuania

France Tunisia

Spain

Ecuador

France

Brazil

Mexico

France

Ecuador

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₀H₁₃N₅O₄
Molecular mass: 267.241 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 58-61-7
DrugBank Drug: DB00640
KEGG Drug: D00045
PubChem Compound: 60961
RxNorm Ingredient: 296
SNOMED-CT Concept: 35431001
Adenosine (substance)
UNII Identifier: K72T3FS567
ADENOSINE